3 active not recruiting, 2 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 3, Completed 2 |
Follow Trisha Wise-Draper: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amivantamab in Adenoid Cystic Carcinoma Amivantamab - Salivary Gland Cancer | Phase 2 | Active not recruiting | Trisha Wise-Draper | 21 | 2022-08-05 | 2026-05-08 |
| Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC Niraparib, Dostarlimab - Head and Neck Cancer | Phase 2 | Completed | Trisha Wise-Draper | 10 | 2020-11-04 | 2026-05-07 |
| Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients Metformin Extended Release Oral Tablet, Pembrolizumab - Head and Neck Squamous Cell Carcinoma | Phase 2 | Active not recruiting | Trisha Wise-Draper | 21 | 2020-08-31 | 2026-05-08 |
| Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy Nivolumab - Head and Neck Cancer | Phase 2 | Completed | Trisha Wise-Draper | 39 | 2017-12-06 | 2026-05-06 |
| Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma Pembrolizumab, Surgery, Radiation Therapy - Head and Neck Cancer | Phase 2 | Active not recruiting | Trisha Wise-Draper | 96 | 2016-01-01 | 2026-05-04 |
Head and Neck Neoplasms (3) · Carcinoma, Adenoid Cystic (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
pembrolizumab (2) · Cisplatin (1) · Metformin (1) · Nivolumab (1) · Radiotherapy (1) · Surgical Procedures, Operative (1) · amivantamab (1) · dostarlimab (1) · niraparib (1)
United States (5)